Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sodium benzoate-induced angioedema-urticaria |
Causative agent (attribute) |
True |
Sodium benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Caffeine and sodium benzoate injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sodium benzoate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Caffeine- and sodium benzoate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing sodium benzoate and sodium phenylacetate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sodium benzoate 100 mg/mL and sodium phenylacetate 100 mg/mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine- and sodium benzoate-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only caffeine and sodium benzoate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium benzoate and sodium phenylacetate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only sodium benzoate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only caffeine and sodium benzoate in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium benzoate- and sodium phenylacetate-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only sodium benzoate and sodium phenylacetate in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sodium benzoate 100 mg/mL and sodium phenylacetate 100 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Sodium benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sodium benzoate 100 mg/mL and sodium phenylacetate 100 mg/mL solution for injection |
Has precise active ingredient |
True |
Sodium benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sodium benzoate-induced angioedema-urticaria |
Causative agent (attribute) |
True |
Sodium benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |